Skip to main content
logo
Arovella Therapeutics Limited (ASX:ALA)
Australia flag Australia · Delayed Price · Currency is AUD
0.0470
-0.0010 (-2.08%)
Oct 1, 2026, 3:50 PM AEST

Arovella Therapeutics Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
57751181474215
Market Cap Growth
-51.07%-36.73%-19.46%246.10%175.83%-43.79%
Enterprise Value
42561071423911
Last Close Price
0.050.060.100.140.050.02

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
16.2421.4334.4475.3429.2152.08
PB Ratio
4.015.305.9013.1011.242.02
P/TBV Ratio
4.015.305.9013.1011.242.06

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
12.1415.8931.0272.9026.8337.85

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Debt / Equity Ratio
-----0.02
Net Debt / Equity Ratio
-1.01-1.01-1.04-1.13-1.37-0.78
Net Debt / EBITDA Ratio
1.891.892.681.440.610.79
Net Debt / FCF Ratio
2.072.072.841.810.810.94
Asset Turnover
0.190.190.200.210.200.03
Quick Ratio
17.2717.2714.066.323.084.05
Current Ratio
17.5117.5114.186.453.224.37
Return on Equity (ROE)
-40.41%-40.41%-47.98%-116.55%-178.67%-103.87%
Return on Assets (ROA)
-26.35%-26.35%-28.30%-59.16%-73.48%-47.72%
Return on Capital Employed (ROCE)
-54.40%-54.40%-39.30%-78.90%-227.80%-98.60%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-12.17%-9.23%-6.34%-5.95%-23.96%-55.95%
FCF Yield
-12.22%-9.27%-6.20%-4.79%-15.06%-40.91%
Buyback Yield / Dilution
-9.47%-9.47%-16.55%-32.32%-29.45%-66.10%